Dyne Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $57.5M | $425.7M | $200.8M |
| FY2022 | $54.0M | $306.3M | $172.1M |
| FY2023 | $73.8M | $165.1M | $121.6M |
| FY2024 | $61.4M | $691.2M | $435.4M |
| FY2025 | $214.8M | $1.19B | $893.4M |